|
|
Guide to Drug Names
What do carfilzomib and PR-171 have in common? They are the same drug! Between the original name, the generic name and the brand name, it is hard to keep myeloma drugs straight. Here's a handy guide put together by Hotline Coordinator Debbie Birns.
|
|
|
03.18.13 |
|
|
|
| bendamustine |
Treanda® |
SDX-105 |
| bortezomib |
VELCADE® |
PS-341 |
| carfilzomib |
Kyprolis® |
PR-171 |
| cyclophosphamide |
Cytoxan® |
|
| daratumumab |
HuMax®-CD38 |
CD38 mAb |
| dasatinib |
Sprycel® |
BMS-354825 |
| delanzomib |
|
CEP 18770 |
| denosumab |
XGEVA® |
AMG-162, osteoprotegerin |
| dinaciclib |
|
SCH 727965 |
| dovitinib |
|
TK-1258 |
| doxorubicin |
Adriamycin®
Doxil® (pegylated liposomal doxorubicin) |
| elotuzumab |
|
HuLuc63 |
| enzastaurin |
|
LY317615 |
| everolimus |
|
RAD001 |
| fenretinide |
|
4-HPR |
| ganetespib |
|
STA-9090 |
| ibrutinib |
|
PCI-32765 |
| imetelstat |
|
GRN-163L |
| ixazomib |
|
MLN9708 |
| lenalidomide |
Revlimid® |
CC-5013 |
| lorvotuzumab |
|
IMGN901, hu-N901 |
| mapatumumab
|
|
HGS-ETR1 |
| marizomib |
|
NPI-0052, salinosporamide A |
| masitinib |
|
AB1010 |
| melphalan |
Alkeran® |
|
| milatuzumab |
|
IMMU-115, hLL1 |
| noscapine
|
|
CB3304 |
| obatoclax |
|
GX015-070 |
| oprozomib |
|
ONS-9012 |
| pamidronate |
Aredia® |
|
| panobinostat |
|
LBH589 |
| pegylated liposomal doxorubicin |
Doxil® |
|
| perifosine
|
|
KRX-0401 |
| plerixafor |
Mozobil® |
AMD3100 |
| plitidepsin |
Aplidin® |
|
| pomalidomide |
Pomalyst® |
CC-4047
|
| rocilinostat |
|
ACY-1215 |
| romidepsin |
Istodax® |
FK228, depsipeptide |
| siltuximab |
|
CNTO 328 |
| sunitinib |
Sutent® |
SU11248 |
| temsirolimus |
Torisel® |
CCI-779 |
| thalidomide |
Thalomid® |
|
| tipifarnib |
Zarnestra® |
R115777 |
| tositumomab |
Bexxar® |
Iodine 131 tositumomab |
| vismodegib |
Erivedge® |
GDC-0449 |
| vorinostat |
Zolinza® |
SAHA |
| zoledronic acid, zoledronate |
Zometa® |
|
|
 related articles
|
|
step 1: get the correct diagnosis
back
print